Global Nuclear Medicine and Radiopharmaceuticals Market Research Report 2026(Status and Outlook)
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.Market DriversThe nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.Market ChallengesDespite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
The global Nuclear Medicine market size was estimated at USD 6875.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine market.
Global Nuclear Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Market Segmentation (by Type)
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Market Segmentation (by Application)
Oncology
Thyroid
Cardiology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclear Medicine Market
Overview of the regional outlook of the Nuclear Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nuclear Medicine market size was estimated at USD 6875.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine market.
Global Nuclear Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Market Segmentation (by Type)
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Market Segmentation (by Application)
Oncology
Thyroid
Cardiology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclear Medicine Market
Overview of the regional outlook of the Nuclear Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Medicine and Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Nuclear Medicine and Radiopharmaceuticals Segment by Type
1.2.2 Nuclear Medicine and Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine and Radiopharmaceuticals Product Life Cycle
3.3 Global Nuclear Medicine and Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine and Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine and Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine and Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Nuclear Medicine and Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine and Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine and Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine and Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine and Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Nuclear Medicine and Radiopharmaceuticals Price by Type (2020-2025)
7 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine and Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.1.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region
8.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.2.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.3.2 North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.4.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.6.2 South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine and Radiopharmaceuticals by Region(2020-2025)
9.2 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine and Radiopharmaceuticals Production
9.4.1 North America Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine and Radiopharmaceuticals Production
9.5.1 Europe Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
9.7.1 China Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Nuclear Medicine and Radiopharmaceuticals Product Overview
10.4.3 Novartis Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Overview
10.7.3 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Nuclear Medicine and Radiopharmaceuticals Product Overview
10.9.3 Bayer Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Overview
10.10.3 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.11.3 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.12.3 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Overview
10.13.3 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Overview
10.14.3 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast
11.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
12.1.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
12.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Medicine and Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Nuclear Medicine and Radiopharmaceuticals Segment by Type
1.2.2 Nuclear Medicine and Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine and Radiopharmaceuticals Product Life Cycle
3.3 Global Nuclear Medicine and Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine and Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine and Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine and Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Nuclear Medicine and Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine and Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine and Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine and Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine and Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Nuclear Medicine and Radiopharmaceuticals Price by Type (2020-2025)
7 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine and Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.1.1 Global Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.1.2 Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region
8.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.2.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.3.2 North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.4.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine and Radiopharmaceuticals Sales by Country
8.6.2 South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine and Radiopharmaceuticals by Region(2020-2025)
9.2 Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine and Radiopharmaceuticals Production
9.4.1 North America Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine and Radiopharmaceuticals Production
9.5.1 Europe Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine and Radiopharmaceuticals Production (2020-2025)
9.7.1 China Nuclear Medicine and Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine and Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Nuclear Medicine and Radiopharmaceuticals Product Overview
10.4.3 Novartis Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Overview
10.7.3 Lantheus Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Nuclear Medicine and Radiopharmaceuticals Product Overview
10.9.3 Bayer Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Overview
10.10.3 Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.11.3 Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Overview
10.12.3 Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Overview
10.13.3 China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Overview
10.14.3 Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 NUCLEAR MEDICINE AND RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast
11.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
12.1.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Medicine and Radiopharmaceuticals by Type (2026-2035)
12.2 Global Nuclear Medicine and Radiopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application
Table 5. Nuclear Medicine and Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine and Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Medicine and Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine and Radiopharmaceuticals as of 2025)
Table 11. Global Market Nuclear Medicine and Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nuclear Medicine and Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine and Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Medicine and Radiopharmaceuticals Sales by Type (K MT)
Table 27. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (M USD)
Table 28. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Nuclear Medicine and Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Application
Table 34. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application
Table 35. Global Nuclear Medicine and Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Medicine and Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Nuclear Medicine and Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 64. Cardinal Health Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 70. GE Healthcare Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 76. Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 82. Novartis Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 87. Curium Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 92. SIEMENS Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 97. Lantheus Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 102. Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Bayer Basic Information
Table 106. Bayer Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 107. Bayer Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bayer Business Overview
Table 109. Bayer Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 112. Eli Lilly Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Aurobindo Pharma Basic Information
Table 116. Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 117. Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Business Overview
Table 119. Aurobindo Pharma Recent Developments
Table 120. Mundipharma Basic Information
Table 121. Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 122. Mundipharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Mundipharma Business Overview
Table 124. Mundipharma Recent Developments
Table 125. China Isotope and Radiation Basic Information
Table 126. China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 127. China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Isotope and Radiation Business Overview
Table 129. China Isotope and Radiation Recent Developments
Table 130. Dongcheng Basic Information
Table 131. Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 132. Dongcheng Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Recent Developments
Table 135. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Nuclear Medicine and Radiopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application
Table 5. Nuclear Medicine and Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine and Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Medicine and Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine and Radiopharmaceuticals as of 2025)
Table 11. Global Market Nuclear Medicine and Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nuclear Medicine and Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine and Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Medicine and Radiopharmaceuticals Sales by Type (K MT)
Table 27. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Type (M USD)
Table 28. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Nuclear Medicine and Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) by Application
Table 34. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application
Table 35. Global Nuclear Medicine and Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Medicine and Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Medicine and Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Nuclear Medicine and Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Medicine and Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nuclear Medicine and Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 64. Cardinal Health Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 70. GE Healthcare Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 76. Jubilant Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 82. Novartis Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 87. Curium Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 92. SIEMENS Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 97. Lantheus Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 102. Bracco Imaging Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Bayer Basic Information
Table 106. Bayer Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 107. Bayer Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bayer Business Overview
Table 109. Bayer Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 112. Eli Lilly Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Aurobindo Pharma Basic Information
Table 116. Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 117. Aurobindo Pharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Business Overview
Table 119. Aurobindo Pharma Recent Developments
Table 120. Mundipharma Basic Information
Table 121. Mundipharma Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 122. Mundipharma Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Mundipharma Business Overview
Table 124. Mundipharma Recent Developments
Table 125. China Isotope and Radiation Basic Information
Table 126. China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 127. China Isotope and Radiation Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Isotope and Radiation Business Overview
Table 129. China Isotope and Radiation Recent Developments
Table 130. Dongcheng Basic Information
Table 131. Dongcheng Nuclear Medicine and Radiopharmaceuticals Product Overview
Table 132. Dongcheng Nuclear Medicine and Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Recent Developments
Table 135. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Nuclear Medicine and Radiopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Medicine and Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine and Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine and Radiopharmaceuticals Product Life Cycle
Figure 13. Nuclear Medicine and Radiopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Medicine and Radiopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Medicine and Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Medicine and Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine and Radiopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Medicine and Radiopharmaceuticals
Figure 19. Global Nuclear Medicine and Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Nuclear Medicine and Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine and Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine and Radiopharmaceuticals by Type in 2025
Figure 29. Market Share of Nuclear Medicine and Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Nuclear Medicine and Radiopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application
Figure 33. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application in 2025
Figure 37. Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine and Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine and Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine and Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region in 2024
Figure 68. China Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine and Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Medicine and Radiopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Medicine and Radiopharmaceuticals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nuclear Medicine and Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Medicine and Radiopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine and Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine and Radiopharmaceuticals Product Life Cycle
Figure 13. Nuclear Medicine and Radiopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Medicine and Radiopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Medicine and Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Medicine and Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine and Radiopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Medicine and Radiopharmaceuticals
Figure 19. Global Nuclear Medicine and Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Nuclear Medicine and Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine and Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine and Radiopharmaceuticals by Type in 2025
Figure 29. Market Share of Nuclear Medicine and Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Nuclear Medicine and Radiopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application
Figure 33. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine and Radiopharmaceuticals Market Share by Application in 2025
Figure 37. Global Nuclear Medicine and Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine and Radiopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine and Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine and Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine and Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine and Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine and Radiopharmaceuticals Market Size by Region in 2024
Figure 68. China Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine and Radiopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine and Radiopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine and Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine and Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine and Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nuclear Medicine and Radiopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Medicine and Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Medicine and Radiopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Medicine and Radiopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Medicine and Radiopharmaceuticals Market Share Forecast by Application (2026-2035)
